Tech Company Financing Transactions
Hopewell Therapeutics Funding Round
Hopewell Therapeutics secured a $25 million Seed funding round on 6/7/2023. Investors included 5Y Capital, Bopu Capital Management and Hike Capital.
Transaction Overview
Company Name
Announced On
6/7/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Proceeds Purpose
The funds will enable the company to advance the development of genomic medicines based on its differentiated ttLNP platform through both internal pipeline programs and external partnerships.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
216 W Cummings Park
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry leading companies. We are developing our own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of our ttLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases and neurological disorders.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/7/2023: Mosaic venture capital transaction
Next: 6/7/2023: Source.ag venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs